CCBIO906 Cancer Genomics, 2025
This 3 ECTS course will provide a broad understanding of aspects of cancer genome biology and their investigation by next-generation sequencing (NGS) technologies. Methods for analyzing DNA variation and structure and RNA expression patterns will be covered, as well as nuclear and chromatin structure. Also, ethical, legal aspects, and hereditary predisposition will be taught.
You will learn:
- what kinds of mutations may predispose for, contribute to, or appear during cancer development
- how these variants can be detected by NGS methods and be analysed bioinformatically
- how to employ these methods to stratify patients both diagnostically and therapeutically
- the different implications of the same aberrations depending on tissue type
- ethical and legal regulations regarding genetic analyses of patient samples
After the course, you should be able to:
- formulate problems, select methods, and plan NGS analyses on samples from cancer patients
- assess the expediency and application of different NGS methods in cancer diagnostics and research
- know the contact points for NGS analysis and data storage and analysis in Bergen
- communicate relevant literature and methods concerning cancer genomics
When:
October 21-23, 2025
Program:
See the preliminary CCBIO906 program here. (external link)
Registration:
If you are already enrolled at the University of Bergen (UiB) and want the 3 ECTS, you register through Studentweb (external link). Deadline is October 1.
If you don't need the 3 ECTS (studiepoeng) registered as part of an education/degree, and just want to join the lectures for professional update, you register through this link (external link). Deadline is October 1.
Note that for all registrations, we cannot confirm your seat until after the deadline and a review of the list.
Who:
Mainly intended for PhD candidates and other students, but open to all. It is highly useful for many more, as knowledge about genome aberrations can help you understand tumor biological mechanisms and guide you to improved diagnosis, targeted treatment, and better follow-up of cancer patients.
Place:
Personal attendance in Birkhaugsalen/room D305, 3rd floor, main building (Sentralblokka), Haukeland University Hospital, Bergen.
Reading list:
will be sent to the participants
Contact:
If you have any questions, please contact academic responsible Erling A. Høivik erling.hoivik@uib.no or course coordinator Siren Fromreide siren.fromreide@uib.no